We generally refer to the quarter ended March 31, 2021 as the "first quarter",
the quarter ending December 31, 2021 as the "fourth quarter" and the quarter
ended March 31, 2020 as the "prior-year quarter". See Analysis of Operations for
a discussion of our non-GAAP performance measures.
The unaudited Consolidated Financial Statements for the three months ended March
31, 2020 have been revised to correct prior period errors as discussed in Note
1, "Basis of Presentation and Summary of Significant Accounting and Financial
Reporting Policies" and Note 18, "Revisions of Previously Issued Unaudited
Consolidated Financial Statements" in the Notes to the unaudited Consolidated
Financial Statements included in Item 1, "Financial Statements" on this
Quarterly Report on Form 10-Q. Accordingly, the tables presented in the
Management's Discussion and Analysis of Financial Condition and Results of
Operations ("MD&A") reflect the impact of those revisions.
Information Related to Forward-Looking Statements
This document contains, and our other public communications may contain,
forward-looking statements, that is, information related to future, not
historical events. Such statements generally include the words "believes,"
"plans," "intends," "targets," "will," "expects," "suggests," "anticipates,"
"outlook," "continues" or similar expressions. Forward-looking statements
include, without limitation, statements about expected financial positions;
results of operations; cash flows; financing plans; business strategy; operating
plans; strategic alternatives; capital and other expenditures; competitive
positions; growth opportunities for existing products; benefits from new
technology and cost reduction initiatives, plans and objectives; and markets for
securities. Like other businesses, we are subject to risks and uncertainties
that could cause our actual results to differ materially from our projections or
that could cause other forward-looking statements to prove incorrect. Factors
that could cause actual results to materially differ from those contained in the
forward-looking statements, or that could cause other forward-looking statements
to prove incorrect, include, without limitation, risks related to: the cyclical
and seasonal nature of the industries that GCP serves; foreign operations,
especially in emerging regions; changes in currency exchange rates; business
disruptions due to public health or safety emergencies, such as the novel strain
of coronavirus ("COVID-19") pandemic; the cost and availability of raw materials
and energy; the effectiveness of GCP's research and development, new product
introductions and growth investments; acquisitions and divestitures of assets
and gains and losses from dispositions; developments affecting GCP's outstanding
liquidity and indebtedness, including debt covenants and interest rate exposure;
developments affecting GCP's funded and unfunded pension obligations; warranty
and product liability claims; legal proceedings; the inability to establish or
maintain certain business relationships and relationships with customers and
suppliers or the inability to retain key personnel; the handling of hazardous
materials and the costs of compliance with environmental regulation, and those
factors set forth in our most recent Annual Report on Form 10-K, this Quarterly
Report on Form 10-Q and Current Reports on Form 8-K, which have been filed with
the Securities and Exchange Commission ("SEC") and are available on the Internet
at www.sec.gov. Our reported results should not be considered as an indication
of our future performance. Readers are cautioned not to place undue reliance on
our projections and forward-looking statements, which speak only as of the date
thereof. We undertake no obligation to publicly release any revisions to the
projections and forward-looking statements contained in this document, or to
update them to reflect events or circumstances occurring after the date of this
document.
                                       34
--------------------------------------------------------------------------------

  Table of Contents
RESULTS OF OPERATIONS
Business Description Summary
We are engaged in the production and sale of specialty construction chemicals
and specialty building materials through two global operating segments:
•Specialty Construction Chemicals. Our Specialty Construction Chemicals ("SCC")
operating segment provides products, services and technologies to the concrete
and cement industries, including concrete add-mixtures and cement, as well as
in-transit monitoring and management systems, which reduce the cost and improve
the performance and quality of cement, concrete, mortar, masonry, and other
cementitious-based construction materials.
•Specialty Building Materials. Our Specialty Building Materials ("SBM")
operating segment produces and sells sheet and liquid membrane systems and other
products that protect both new and existing structures from water, air, and
vapor penetration, as well as from fire damage. We also manufacture and sell
specialized cementitious and chemical grouts used for soil consolidation and
leak-sealing applications in addition to a moisture barrier system and
installation tools for the flooring industry.
We operate our business on a global scale. During the first quarter,
approximately 50% of our sales were generated outside of the U.S. We operate and
have locations in over 30 countries and transact business in over 30 currencies.
We manage our operating segments on a global basis to serve global markets.
Currency fluctuations affect our reported results of operations, cash flows, and
financial position.
Impact of COVID-19 Pandemic
The global health crisis caused by the novel coronavirus ("COVID-19") outbreak
and its resurgences has and will continue to negatively impact global economic
activity, which, despite progress in vaccination efforts, remains uncertain and
cannot be predicted with confidence. We have been closely monitoring the impact
of COVID-19 and managing its effects on our business globally as the situation
continues to evolve. During the first quarter, we saw an improvement in business
conditions and construction market activity as global economies began to reopen.
The impact of COVID-19 on our business varied across different geographies and
product lines during the first quarter and the prior-year quarter. We have taken
actions to preserve our liquidity by reducing discretionary spending.
It is difficult for us to predict at this time the duration and extent of the
impact of COVID-19 on the global construction industry and our business,
financial position, results of operations, and liquidity although we expect that
managing the impacts of the pandemic will be a part of our ongoing operations
for the foreseeable future. We are focused on protecting the health, safety and
well-being of our employees in accordance with guidelines issued by national and
other health and safety authorities, while seeking to meet the needs of our
global customers and suppliers. Responsive measures we adopted include working
remotely when possible, establishing procedures for deep cleaning of facilities,
restricting business travel, providing personal protective equipment, using
appropriate social distancing practices, and restricting visitor access to our
facilities.
We are monitoring a number of factors to assess the potential duration and
extent of the impact of COVID-19 on our operations, including the health of the
global economy and construction industry, specifically on demand drivers for our
construction products, as well as operational disruptions including those
resulting from government actions, such as mandatory halts of construction
activity, travel restrictions, as well as facility and work site closures. We
will continue to prioritize the health and safety of our employees and serving
our customers while minimizing disruption to the extent possible. We will also
continue to monitor the health of the construction industry in the geographic
markets in which we operate and respond accordingly.
The following is an overview of our financial performance for the first quarter
compared with the prior-year quarter.

                                       35
--------------------------------------------------------------------------------

Table of Contents


                                                                             Three Months Ended March 31,
(In millions, except per share amounts)                               2021                2020             % Change
Net sales                                                       $      222.8           $ 216.7                   2.8  %
Cost of goods sold                                                     136.3             133.9                   1.8  %
Gross profit                                                            86.5              82.8                   4.5  %
Gross margin                                                            38.8   %          38.2  %               0.6 pts
Selling, general and administrative expenses                            66.6              68.1                  (2.2) %
Research and development expenses                                        4.5               4.9                  (8.2) %
Interest expense and related financing costs                             5.6               5.7                  (1.8) %
Repositioning expenses                                                   1.3               2.7                 (51.9) %
Restructuring expenses and asset write offs                              7.6               3.1                       NM

Other income, net                                                       (1.7)             (2.2)                (22.7) %
Total costs and expenses                                                83.9              82.3                   1.9  %
Income from continuing operations before income taxes                    2.6               0.5                       NM
(Provision for) benefit from income taxes                               (1.0)              1.6                       NM
Income from continuing operations                                        1.6               2.1                 (23.8) %
Loss from discontinued operations, net of income taxes                     -              (0.3)                100.0  %
Net income                                                               1.6               1.8                 (11.1) %
Less: Net income attributable to noncontrolling interests               (0.1)             (0.1)                    -  %
Net income attributable to GCP shareholders                     $        1.5           $   1.7                 (11.8) %

Income from continuing operations attributable to GCP shareholders

$        1.5           $   2.0                 (25.0) %

Diluted EPS from continuing operations attributable to GCP shareholders

$       0.02           $  0.03                 (33.3) %
Net sales:
Specialty Construction Chemicals                                $      123.9           $ 125.4                  (1.2) %
Specialty Building Materials                                            98.9              91.3                   8.3  %
Total GCP net sales                                             $      222.8           $ 216.7                   2.8  %
Net sales by region:
North America                                                   $      118.1           $ 119.2                  (0.9) %
Europe Middle East Africa (EMEA)                                        44.6              44.3                   0.7  %
Asia Pacific                                                            46.7              40.3                  15.9  %
Latin America                                                           13.4              12.9                   3.9  %
Total net sales by region                                       $      222.8           $ 216.7                   2.8  %



First Quarter Performance Summary
Following is a summary of our financial performance for the first quarter
compared with the prior-year quarter.
•Net sales increased 2.8% to $222.8 million.
•Gross profit increased 4.5% to $86.5 million; gross margin increased
approximately 60 basis points to 38.8%.
•Selling, general, and administrative expenses decreased 2.2% to $66.6 million.
•Income from continuing operations attributable to GCP shareholders was $1.5
million, or $0.02 per diluted share, compared to $2.0 million, or $0.03 per
diluted share, for the prior-year quarter.
                                       36
--------------------------------------------------------------------------------

  Table of Contents
GCP Overview
Net Sales and Gross Margin
                    [[Image Removed: gcpwi-20210331_g1.jpg]]

The following table identifies the period-over-period increase or decrease in sales attributable to changes in volume and/or mix, product price, and the impact of currency translation for the period.

Three Months Ended March 31, 2021

as a Percentage Increase (Decrease) from


                                                                                        March 31, 2020
                                                                                                      Currency
Net Sales Variance Analysis                               Volume                Price                Translation            Total Change
Specialty Construction Chemicals                              (1.7) %              (0.3) %                    0.8  %              (1.2) %
Specialty Building Materials                                   6.2  %              (0.2) %                    2.3  %               8.3  %
Net sales                                                      1.6  %              (0.3) %                    1.5  %               2.8  %
By Region:
North America                                                 (0.3) %              (0.7) %                    0.1  %              (0.9) %
Europe Middle East Africa                                     (6.0) %              (0.1) %                    6.8  %               0.7  %
Asia Pacific                                                  12.0  %              (0.9) %                    4.8  %              15.9  %
Latin America                                                 13.3  %               5.4  %                  (14.8) %               3.9  %


Net sales of $222.8 million for the first quarter increased $6.1 million, or
2.8%, from the prior-year quarter primarily due to higher sales volumes and
favorable impact of foreign currency translation. Sales volumes in SBM were
higher in the first quarter in North America and Asia Pacific, partially offset
by lower volumes in EMEA due to the impact of COVID-19. Sales volumes in SCC
were lower in the first quarter in North America and EMEA, partially offset by
higher volumes in Latin America and Asia Pacific.
Gross profit of $86.5 million for the first quarter increased $3.7 million, or
4.5%, from the prior-year quarter primarily due to higher sales volumes,
partially offset by unfavorable impact of product and geographic mix. Gross
margin increased 60 basis points to 38.8% primarily due to improved operational
productivity, partially offset by unfavorable impact of product and geographic
mix.


                                       37

--------------------------------------------------------------------------------

  Table of Contents
Selling, General, and Administration Expenses
Selling, general and administrative costs of $66.6 million decreased $1.5
million, or 2.2%, for the first quarter compared to the prior-year quarter
primarily due to shareholder activism and other related costs incurred during
the prior-year quarter and lower employee-related costs resulting from
restructuring programs. These favorable impacts were partially offset by higher
employee incentive compensation costs and higher facility costs related to
corporate headquarters.
                                       38
--------------------------------------------------------------------------------

  Table of Contents
Restructuring and Repositioning Expenses
2021 Restructuring Plan
On March 30, 2021, our Board of Directors (the "Board") approved a business
restructuring and repositioning plan (the "2021 Plan") related to the relocation
of our corporate headquarters to the Atlanta, Georgia area, the closure of the
Cambridge, Massachusetts campus, the build-out of a new global research and
development center near the Boston /Cambridge area, as well as the consolidation
of other regional facilities and offices, including an organizational redesign,
which is expected to lower costs.
Cumulative costs incurred under the 2021 Plan since its inception were $6.6
million with expected total costs of $26 million- $29 million. We expect to
realize total pre-tax cost structure savings associated with the 2021 Plan of
approximately $13 million to $15 million mostly in general, administrative and
overhead costs, with most of the savings occurring in 2022. These savings are
expected to benefit both the Specialty Construction Chemicals and Specialty
Building Materials operating segments and result in overall general
administrative and overhead cost reductions. Substantially all of the
restructuring actions under the 2021 Plan are expected to be completed by June
30, 2022. With the exception of asset write offs, substantially all of the
restructuring and repositioning activities are expected to be settled in cash.
2019 Phase 2 Restructuring and Repositioning Plan (the "2019 Phase 2 Plan")
On July 31, 2019, the Board approved a business restructuring and repositioning
plan to further optimize the design and footprint of the Company's global
organization, primarily with respect to its general administration and business
support functions, and streamline cross-functional activities.
Cumulative costs incurred under the 2019 Phase 2 Plan since its inception were
$33.8 million. We achieved total annualized pre-tax cost savings through a
reduction in general and administrative expenses under the 2019 Phase 2 Plan of
approximately $13.3 million as of March 31, 2021, which benefited both the SCC
and the SBM operating segments and Corporate function. We expect to achieve
total estimated cost savings of approximately $20 million. With the exception of
asset write offs, substantially all of the restructuring and repositioning
activities are expected to be settled in cash, and the program was substantially
completed as of March 31, 2021.
2019 Restructuring and Repositioning Plan (the "2019 Plan")
On February 22, 2019, the Board approved a business restructuring and
repositioning plan (the "2019 Plan"). The 2019 Plan is focused on our global
supply chain strategy, processes and execution, including our manufacturing,
purchasing, logistics, and warehousing operations. The plan also addresses our
service delivery model, primarily in North America, to streamline the Company's
pursuit of combined admixture and VERIFI® opportunities.
Cumulative costs incurred under the 2019 Plan since its inception were
$12.6 million. We achieved annualized pre-tax cost savings of $17 million
through a reduction in cost of goods sold as a result of supply chain, warehouse
operations, and logistical enhancements that benefited both the SCC and SBM
operating segments under the 2019 Plan. We expect to achieve total estimated
cost savings of approximately $19 million. Substantially all of the activities
under the 2019 Plan were completed as of December 31, 2020.
For further information on our restructuring expenses, please refer to Note 12,
"Restructuring and Repositioning Expenses, Asset Write Offs" in the Notes to the
unaudited Consolidated Financial Statements included in Item 1, "Financial
Statements" on this Quarterly Report on Form 10-Q, and Note 14, "Restructuring
and Repositioning Expenses, Asset Write Offs" to the Company's Consolidated
Financial Statements included in the 2020 Annual Report in the Form 10-K.

                                       39
--------------------------------------------------------------------------------

  Table of Contents
Pension Expense
Defined benefit expense includes costs relating to U.S. and non-U.S. defined
benefit pension and other postretirement benefit (the "OPEB") plans that provide
benefits for retirees and former employees of divested businesses where we
retained these obligations.
"Certain pension costs" represent ongoing costs recognized quarterly, including
service and interest costs, expected return on plan assets and amortization of
prior service costs/credits. Certain pension costs were $1.4 million and $1.3
million, respectively, during the first quarter and the prior-year quarter. We
did not incur any "pension market-to-market adjustment and other related costs"
in the first quarter or the prior-year quarter.
Other Income, Net
Other income, net consists primarily of interest income, foreign currency
exchange gains (losses), defined benefit pension expenses exclusive of service
costs, income from our Transition Services Agreement related to the sale of
Darex, and other items.
Other income, net was $1.7 million and $2.2 million, respectively, during the
first quarter and the prior-year quarter. The decrease of $0.5 million was
primarily due to lower interest income.
Income Taxes
Income taxes attributable to continuing operations during the first quarter and
the prior-year quarter was income tax expense (benefit) of $1.0 million and
$(1.6) million, respectively, representing effective tax rates of 38.5% and
(320.0)%, respectively.
The difference between the U.S. federal income tax rate of 21.0% and our overall
income tax rate for the for the first quarter was primarily due to tax expense
on unrecognized tax benefits of $0.3 million. The difference between the U.S.
federal income tax rate of 21.0% and our overall income tax rate during the
prior-year quarter was primarily due to benefits recognized as a result of the
Coronavirus Aid Relief and Economic Security ("CARES") Act. The CARES Act
allowed for accelerated interest and depreciation deductions which caused
estimated net operating losses in 2019 and 2020. Under the CARES Act, those
losses can be carried back to offset prior taxable income previously taxed at
the U.S. federal income tax rate of 35% resulting in an income tax benefit of
$2.8 million, offset by increases in unrecognized tax benefits of $0.4 million
and valuation allowance expense of $0.6 million.
In general, it is our practice and intention to permanently reinvest the
earnings of our foreign subsidiaries and repatriate earnings only when tax
efficient.
Income from Continuing Operations Attributable to GCP Shareholders
                    [[Image Removed: gcpwi-20210331_g2.jpg]]
                                       40
--------------------------------------------------------------------------------

  Table of Contents
Income from continuing operations attributable to GCP shareholders was $1.5
million for the first quarter compared to $2.0 million for the prior-year
quarter. The decrease was primarily attributable to higher restructuring and
repositioning costs and higher income tax expense, partially offset by higher
gross profit and lower selling, general and administrative expenses.
On July 3, 2017, we completed the sale of our Darex business to Henkel AG & Co.
KGaA ("Henkel"). The results of operations of the Darex segment are presented as
discontinued operations and, as such, have been excluded from continuing
operations and segment results for all periods presented. Unless otherwise
noted, the discussion and analysis pertains only to our continuing operations.
                                       41
--------------------------------------------------------------------------------

  Table of Contents
Operating Segment Overview
The following is an overview of the financial performance of the SCC and SBM
operating segments for the first quarter compared with the prior-year quarter.
For further information on our accounting policies related to allocating certain
functional and corporate costs and measuring segment operating income, please
refer to Note 17, "Operating Segment and Geographic Information" in the Notes to
the unaudited Consolidated Financial Statements included in Item 1, "Financial
Statements" on this Quarterly Report on Form 10-Q. Refer to the table in the
"Analysis of Operations" section below for the related segment financial
performance information.
Segment operating margin is defined as segment operating income divided by
segment net sales. It represents an operating performance measure related to
ongoing earnings and trends in our operating segments that are engaged in
revenue generation and other core business activities. We use this metric to
allocate resources between the segments and assess our strategic and operating
decisions related to core operations of our business.
Specialty Construction Chemicals (SCC)
Net Sales and Gross Margin
                    [[Image Removed: gcpwi-20210331_g3.jpg]]
Net sales were $123.9 million for the first quarter, a decrease of $1.5 million,
or 1.2%, compared with the prior-year quarter. The decrease was primarily due to
lower sales volumes, partially offset by the favorable impact of foreign
currency translation. Sales volumes were lower in North America and EMEA,
partially offset by higher volumes in Latin America and Asia Pacific.
Sales volumes decreased 1.7% in the first quarter compared with the prior-year
quarter resulting primarily from self-manufacturing from certain customers.
Concrete and Cement volumes decreased 2.0% and 0.8%, respectively.
Gross profit was $45.4 million for the first quarter, a decrease of $2.2
million, or 4.6%, compared with the prior-year quarter, primarily due to lower
sales volumes. Gross margin decreased 140 basis points to 36.6% compared with
the prior-year quarter primarily due to unfavorable impact of product mix,
partially offset by lower costs resulting from improved operational and
logistics productivity.





                                       42

--------------------------------------------------------------------------------

Table of Contents

Segment Operating Income and Operating Margin


                    [[Image Removed: gcpwi-20210331_g4.jpg]]
Segment operating income of $6.1 million for the first quarter decreased $2.4
million, or 28.2%, compared with the prior-year quarter primarily due to lower
gross profit, as well as higher depreciation and amortization costs related to
our growth initiatives. Segment operating margin of 4.9% decreased 190 basis
points compared with the prior-year quarter primarily due to lower gross margin.


                                       43
--------------------------------------------------------------------------------

  Table of Contents
Specialty Building Materials (SBM)
Net Sales and Gross Margin
                    [[Image Removed: gcpwi-20210331_g5.jpg]]
Net sales were $98.9 million for the first quarter, an increase of $7.6 million,
or 8.3%, compared with the prior-year quarter primarily due to higher sales
volumes in North America and Asia Pacific, partially offset by lower volumes in
EMEA, as well as the favorable impact of foreign currency translation.
Residential volumes increased 69.2% driven by the strong demand in North America
for roofing materials and the timing of our promotional activity. Building
Envelope and Specialty Construction Products volumes declined 7.1% and 1.5%,
respectively, in the first quarter compared with the prior-year quarter
primarily due to lower construction activity.
Gross profit was $41.4 million for the first quarter, an increase of $5.8
million, or 16.3%, from the prior-year quarter, while gross margin increased 290
basis points to 41.9% primarily due to improved productivity related to raw
material utilization and higher sales volumes resulting in improved operating
leverage.


                                       44

--------------------------------------------------------------------------------

  Table of Contents
Segment Operating Income and Operating Margin
                    [[Image Removed: gcpwi-20210331_g6.jpg]]
Segment operating income of $19.4 million for the first quarter increased by
$5.3 million, or 37.6%, compared with the prior-year quarter primarily due to
higher gross profit. Segment operating margin increased 420 basis points to
19.6% primarily due to higher gross margin.
Analysis of Operations
We have set forth in the table below our key operating statistics with
percentage changes for the first quarter compared to the corresponding
prior-year quarter. In the Analysis of Operations (the "table"), we present
financial information in accordance with U.S. GAAP, as well as certain non-GAAP
financial measures, which we describe below in further detail.
We believe that the non-GAAP financial information supplements our discussions
about the performance of our businesses, improves quarter-to-quarter and
year-over-year comparability, and provides insight into the information that our
management uses to evaluate the performance of our businesses. Our management
uses GAAP and non-GAAP measures in financial and operational decision-making
processes, for internal reporting, and as part of forecasting and budgeting
processes since non-GAAP measures provide additional transparency into our core
operations.
In the table, we have provided reconciliations of these non-GAAP financial
measures to the most directly comparable financial measures calculated and
presented in accordance with U.S. GAAP. These non-GAAP financial measures should
not be considered substitutes for financial measures calculated in accordance
with U.S. GAAP, and the financial results that we calculate and present in the
table in accordance with U.S. GAAP, as well as the corresponding reconciliations
from those results, should be carefully evaluated as part of this Quarterly
Report on Form 10-Q.
                                       45
--------------------------------------------------------------------------------

  Table of Contents
The following are the non-GAAP financial measures presented in the table:
•Adjusted EBIT (a non-GAAP financial measure)- is defined as net income (loss)
from continuing operations attributable to GCP shareholders adjusted for: (i)
gains and losses on sales of businesses, product lines and certain other
investments; (ii) currency and other financial losses in Venezuela; (iii) costs
related to legacy product, environmental and other claims; (iv) restructuring
and repositioning expenses, and asset write offs; (v) defined benefit plan costs
other than service and interest costs, expected returns on plan assets and
amortization of prior service costs/credits; (vi) third-party and other
acquisition-related costs; (vii) other financing costs associated with the
modification or extinguishment of debt; (viii) amortization of acquired
inventory fair value adjustments; (ix) tax indemnification adjustments; (x)
interest income, interest expense and related financing costs; (xi) income
taxes; (xii) shareholder activism and other related costs; (xiii) gain on sale
of corporate headquarters, net of related costs; and (xiv) certain other items
that are not representative of underlying trends. Adjusted EBIT Margin is
defined as Adjusted EBIT divided by net sales. We use Adjusted EBIT to assess
and measure our operating performance and determine performance-based employee
compensation. We use Adjusted EBIT as a performance measure because it provides
improved quarter-to-quarter and year-over-year comparability for decision-making
and compensation purposes and allows management to measure the ongoing earnings
results of our strategic and operating decisions.
•Adjusted EBITDA (a non-GAAP financial measure)- is defined as Adjusted EBIT
adjusted for depreciation and amortization. Adjusted EBITDA Margin is defined as
Adjusted EBITDA divided by net sales. We use Adjusted EBITDA as a performance
measure in making significant business decisions.
•Adjusted Earnings Per Share (a non-GAAP financial measure)- is defined as
earnings per share ("EPS") from continuing operations on a diluted basis
adjusted for: (i) gains and losses on sales of businesses, product lines and
certain other investments; (ii) currency and other financial losses in
Venezuela; (iii) costs related to legacy product, environmental and other
claims; (iv) restructuring and repositioning expenses and asset write offs; (v)
defined benefit plan costs other than service and interest costs, expected
returns on plan assets and amortization of prior service costs/credits; (vi)
third-party and other acquisition-related costs; (vii) other financing costs
associated with the modification or extinguishment of debt; (viii) amortization
of acquired inventory fair value adjustments; (ix) tax indemnification
adjustments; (x) shareholder activism and other related costs; (xi) certain
discrete tax items; (xii) gain on sale of corporate headquarters, net of related
costs; and (xiii) certain other items that are not representative of underlying
trends. We use Adjusted EPS as a performance measure to review our diluted
earnings per share results on a consistent basis and in determining certain
performance-based employee compensation.
•Adjusted Gross Profit (a non-GAAP financial measure)- is defined as gross
profit adjusted for: (i) corporate and pension-related costs included in cost of
goods sold; (ii) loss in Venezuela included in cost of goods sold; (iii)
amortization of acquired inventory fair value adjustment; and (iv) certain other
items that are not representative of underlying trends. Adjusted Gross Margin
means Adjusted Gross Profit divided by net sales. We use this performance
measure to understand trends and changes and to make business decisions
regarding core operations.
Adjusted EBIT, Adjusted EBIT Margin, Adjusted EBITDA, Adjusted EBITDA Margin,
Adjusted EPS, Adjusted Gross Profit and Adjusted Gross Margin do not purport to
represent income measures as defined in accordance with U.S. GAAP. These
measures are provided to investors and others to improve the quarter-to-quarter,
year-to-year, and peer-to-peer comparability of our financial results and to
ensure that investors understand the information we use to evaluate the
performance of our businesses.
                                       46
--------------------------------------------------------------------------------

  Table of Contents
Adjusted EBIT has material limitations as an operating performance measure
because it excludes costs related to income and expenses from restructuring and
repositioning activities which historically has been a material component of our
net income (loss) from continuing operations attributable to GCP shareholders.
Adjusted EBITDA also has material limitations as an operating performance
measure because it excludes the impact of depreciation and amortization expense.
Our business is substantially dependent on the successful deployment of capital,
and depreciation and amortization expense is a necessary element of our costs.
We compensate for the limitations of these measurements by using these
indicators together with net income (loss) measured in accordance with U.S. GAAP
to present a complete analysis of our results of operations. Adjusted EBIT and
Adjusted EBITDA should be evaluated together with net income (loss) from
continuing operations attributable to GCP shareholders measured in accordance
with U.S. GAAP for a complete understanding of our results of operations.

                                       47
--------------------------------------------------------------------------------

  Table of Contents
We have provided in the following tables a reconciliation of these non-GAAP
measures to the most directly comparable financial measures calculated and
presented in accordance with U.S. GAAP.
Analysis of Operations                                                     Three Months Ended March 31,
(In millions, except per share amounts)                          2021                 2020                % Change

Profitability performance measures:
Adjusted EBIT (A):
Specialty Construction Chemicals segment operating income  $        6.1           $     8.5                     (28.2) %
Specialty Building Materials segment operating income              19.4                14.1                      37.6  %
Corporate costs (B)                                                (7.2)               (5.9)                     22.0  %
Certain pension costs (C)                                          (1.4)               (1.3)                      7.7  %
Adjusted EBIT (non-GAAP)                                   $       16.9           $    15.4                       9.7  %

Repositioning expenses                                             (1.3)               (2.7)                    (51.9) %
Restructuring expenses and asset write offs                        (7.6)               (3.1)                          NM

Shareholder activism and other related costs (D)                      -                (3.6)                    100.0  %

Third-party and other acquisition-related costs                    (0.1)               (0.5)                    (80.0) %
Interest expense, net                                              (5.4)               (5.1)                      5.9  %
Income tax (provision) benefit                                     (1.0)                1.6                           NM

Income from continuing operations attributable to GCP shareholders

$        1.5           $     2.0                     (25.0) %

Income from continuing operations attributable to GCP shareholders as a percentage of net sales

                           0.7   %             0.9  %                 (0.2) pts

Diluted EPS from continuing operations (U.S. GAAP) $ 0.02

      $    0.03                     (33.3) %
Adjusted EPS (non-GAAP)                                    $       0.12           $    0.10                      20.0  %



                                       48

--------------------------------------------------------------------------------

  Table of Contents
Analysis of Operations                                                  Three Months Ended March 31,
(In millions)                                                  2021                2020                % Change

Gross Profit:
Specialty Construction Chemicals                         $       45.4           $   47.6                     (4.6) %
Specialty Building Materials                                     41.4               35.6                     16.3  %
Adjusted Gross Profit (non-GAAP)                                 86.8               83.2                      4.3  %

Corporate costs and pension costs in cost of goods sold (C)

                                                              (0.3)              (0.4)                   (25.0) %
Total GCP Gross Profit (U.S. GAAP)                       $       86.5           $   82.8                      4.5  %
Gross Margin:
Specialty Construction Chemicals                                 36.6   %           38.0  %                (1.4) pts
Specialty Building Materials                                     41.9   %           39.0  %                  2.9 pts
Adjusted Gross Margin (non-GAAP)                                 39.0   %           38.4  %                  0.6 pts

Corporate costs and pension costs in cost of goods sold (0.1) %

         (0.2) %                  0.1 pts
Total GCP Gross Margin (U.S. GAAP)                               38.8   %           38.2  %                  0.6 pts

Adjusted EBIT (A)(B)(C): Specialty Construction Chemicals segment operating income

$        6.1           $    8.5                    (28.2) %
Specialty Building Materials segment operating income            19.4               14.1                     37.6  %
Corporate and certain pension costs                              (8.6)              (7.2)                    19.4  %
Total GCP Adjusted EBIT (non-GAAP)                       $       16.9           $   15.4                      9.7  %
Depreciation and amortization:
Specialty Construction Chemicals                         $        6.9           $    6.4                      7.8  %
Specialty Building Materials                                      3.8                3.6                      5.6  %
Corporate                                                         0.6                1.0                    (40.0) %
Total GCP depreciation and amortization                  $       11.3           $   11.0                      2.7  %
Adjusted EBITDA:
Specialty Construction Chemicals                         $       13.0           $   14.9                    (12.8) %
Specialty Building Materials                                     23.2               17.7                     31.1  %
Corporate and certain pension costs                              (8.0)              (6.2)                    29.0  %
Total GCP Adjusted EBITDA (non-GAAP)                     $       28.2           $   26.4                      6.8  %
Adjusted EBIT Margin:
Specialty Construction Chemicals                                  4.9   %            6.8  %                (1.9) pts
Specialty Building Materials                                     19.6   %           15.4  %                  4.2 pts
Total GCP Adjusted EBIT Margin (non-GAAP)                         7.6   %            7.1  %                  0.5 pts
Adjusted EBITDA Margin:
Specialty Construction Chemicals                                 10.5   %           11.9  %                (1.4) pts
Specialty Building Materials                                     23.5   %           19.4  %                  4.1 pts
Total GCP Adjusted EBITDA Margin (non-GAAP)                      12.7   %           12.2  %                  0.5 pts



                                       49

--------------------------------------------------------------------------------

Table of Contents



(A)Our segment operating income includes only our share of income of
consolidated joint ventures.
(B)Management allocates certain corporate costs to each operating segment to the
extent such costs are directly attributable to the segments.
(C)Certain pension costs include only ongoing costs, recognized quarterly, which
include service and interest costs, expected returns on plan assets and
amortization of prior service costs/credits. "Corporate costs and pension costs
in cost of goods sold" represent service costs related to our manufacturing
employees. Corporate costs do not include any amounts for pension expense. Other
pension-related costs, including annual mark-to-market adjustments, gains or
losses from curtailments and terminations, as well as other related costs, are
excluded from Adjusted EBIT. These amounts are not used by management to
evaluate the performance of our businesses and significantly affect the
peer-to-peer and period-to-period comparability of our financial results.
Mark-to-market adjustments and other related costs are primarily attributable to
changes in financial market values and actuarial assumptions and are not
directly related to the operation of our businesses.
(D)Shareholder activism and other related costs consist primarily of
professional fees incurred in connection with the actions by certain of our
shareholders seeking changes in the composition of our Board of Directors and
nomination of candidates to stand for election at the 2020 Annual Shareholders'
Meeting, as well as other related matters.
NM•Not meaningful.

Corporate Costs
Corporate costs include certain functional support costs, the impacts of foreign
exchange, certain performance-based employee incentive compensation, public
company costs, and other costs that are not allocated or directly attributable
to our operating segments.

Corporate costs were $7.2 million for the first quarter, an increase of $1.3
million, or 22.0%, compared with the prior-year quarter. The increase was
primarily related to higher employee incentive compensation and increased
facility and public company costs, partially offset by cost savings attributable
to our restructuring programs.

Adjusted EBIT
Adjusted EBIT was $16.9 million for the first quarter, an increase of 9.7%
compared with the prior-year quarter primarily due to higher SBM operating
income, partially offset by lower SCC operating income and higher corporate
costs.
Adjusted EBIT margin was 7.6% for the first quarter, an increase of 50 basis
points, primarily due to higher gross margin.
Adjusted EBITDA
Adjusted EBITDA was $28.2 million for the first quarter, an increase of 6.8%
compared with the prior-year quarter, primarily due to higher Adjusted EBIT.

Adjusted EBITDA Margin was 12.7% for the first quarter, an increase of 50 basis
points compared to the prior-year quarter, primarily due to higher Adjusted EBIT
margin.
                                       50
--------------------------------------------------------------------------------

  Table of Contents
Adjusted EPS
Adjusted EPS was $0.12 per diluted share in the first quarter compared to $0.10
in the prior-year quarter.
The following table reconciles Diluted EPS (U.S. GAAP) to Adjusted EPS
(non-GAAP):
                                                                                            Three Months Ended March 31,
                                                                       2021                                                               2020
                                             Pre-                              After-            Per            Pre-                              After-            Per
(In millions, except per share amounts)      Tax           Tax Effect            Tax            Share           Tax           Tax Effect            Tax            Share
Diluted EPS from continuing operations
(U.S. GAAP)                                                                                   $ 0.02                                                             $ 0.03
Repositioning expenses                     $ 1.3          $      0.3          $  1.0            0.01          $ 2.7          $      0.7          $  2.0            0.03
Restructuring expenses and asset write
offs                                         7.6                 1.9             5.7            0.08            3.1                 0.8             2.3            0.03

Shareholder activism and other related
costs                                          -                   -               -               -            3.6                 0.9             2.7            0.04

Third-party and other acquisition-related
costs                                        0.1                   -             0.1               -            0.5                 0.1             0.4            0.01
Discrete tax and other items, including
adjustments to uncertain tax positions         -                (0.4)            0.4            0.01              -                 2.6            (2.6)          (0.04)
Adjusted EPS (non-GAAP)                                                                       $ 0.12                                                             $ 0.10



FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES
The following is an analysis of our financial condition, liquidity and capital
resources at March 31, 2021.
At March 31, 2021 and December 31, 2020, we had $472.9 million and $482.7
million, respectively, in cash and cash equivalents. Cash inflows (outflows)
from operating, investing and financing activities related to continuing
operations were $0.7 million, $(8.1) million and $0.6 million, respectively,
during the first quarter. Cash inflows (outflows) from operating, investing and
financing activities related to continuing operations were $14.3 million, $(8.8)
million and $(0.1) million, respectively, during the prior-year quarter. Our
principal uses of cash generally consist of capital investments, acquisitions
and working capital investments. It is difficult for us to predict at this time
the duration and extent of the impact of COVID-19 on our business, financial
position, results of operations, or liquidity. Due to this uncertainty, we
believe our results of operations and cash flows may be significantly impacted
in future periods. We have significant liquidity and capital resources, and we
are actively managing our cash flow by reducing planned capital expenditures and
managing operating expenses and discretionary spending. We believe our liquidity
and capital resources, including cash on hand and cash we expect to generate
during 2021 and thereafter, future borrowings, if any, as well as other
available liquidity and capital resources discussed further below, are
sufficient to finance our operations and growth strategy and to meet our debt
obligations.

                                       51
--------------------------------------------------------------------------------

  Table of Contents
Sale and Relocation of Corporate Headquarters
On July 31, 2020, we sold our corporate headquarters located at 62 Whittemore
Avenue, Cambridge, Massachusetts 02140 to IQHQ, L.P, entered into a leaseback
transaction with the buyer, and received from the buyer cash proceeds of
$122.5 million, net of the related transaction costs and commissions of $2.5
million, pursuant to the sale of the property. During 2020, we made cash tax
payments of approximately $15 million related to the gain on sale of $110.2
million and expect to make additional cash tax payments of approximately $13
million in future years. The lease commenced on July 31, 2020 and has an initial
rent-free term of eighteen months which can be extended for an additional six
months at our option, subject to monthly rental payments of $0.6 million. The
exercise of the extension option was not reasonably certain as of March 31,
2021. Pursuant to the terms of the lease, we are required to make certain
payments for real estate taxes and other operating expenses related to the
property.
On March 30, 2021, the Board approved a business restructuring and repositioning
plan which is focused on relocation of our corporate headquarters to the
Atlanta, Georgia metro area with a planned opening by the fourth quarter of
2021, the closure of the Cambridge, Massachusetts facility and the build-out of
a new global research and development center near the Boston /Cambridge area,
amongst other things. We expect to incur approximately $6 million of capital
expenditures mostly related to the build-out of the global R&D facility,
corporate headquarters and information technology infrastructure associated with
the relocation.
Share Repurchase Program
On July 30, 2020, our Board of Directors authorized a program to repurchase up
to $100 million of our common stock which is effective through July 30, 2022.
Share repurchases under the program may be made from time to time at Board's
discretion through open market purchases or privately negotiated transactions in
accordance with applicable federal securities laws, including Rule 10b-18 of the
Exchange Act. The share repurchase program is subject to a periodic review by
the Board and may be suspended periodically or discontinued at any time. We plan
to fund repurchases from our existing cash balance. We did not repurchase any
shares during the first quarter.
Cash Resources and Available Credit Facilities
At March 31, 2021, we had available liquidity of $862.0 million, consisting of
$472.9 million in cash and cash equivalents, of which $317.7 million was held in
the U.S., $347.4 million available under our revolving credit facility, and
$41.7 million available under various non-U.S. credit facilities.
Our non-U.S. credit facilities are extended to various subsidiaries that use
them primarily to issue bank guarantees supporting trade activity and provide
working capital during occasional cash shortfalls in certain foreign entities.
We generally renew these credit facilities as they expire.
We expect to meet our U.S. cash and liquidity requirements with cash on hand,
cash we expect to generate during 2021 and thereafter, future borrowings, if
any, and other available liquidity, including royalties and service fees from
our foreign subsidiaries. We may also repatriate future earnings from foreign
subsidiaries if that results in minimal or no U.S. tax consequences. We expect
to have sufficient cash and liquidity to finance our U.S. operations and growth
strategy and meet our debt obligations in the U.S. Please refer to Note 1,
"Basis of Presentation and Summary of Significant Accounting and Financial
Reporting Policies," to the Company's Consolidated Financial Statements included
in the 2020 Annual Report in the Form 10-K for a discussion of our cash and cash
equivalents.
                                       52
--------------------------------------------------------------------------------

  Table of Contents
The following table summarizes our non-U.S. credit facilities as of March 31,
2021:
(In millions)      Maximum Borrowing Amount      Available Liquidity        Maturity Date
Singapore         $                    6.0      $                6.0              4/15/2023
China                                  6.0                       5.5              4/15/2023
Australia                              5.5                       4.9              4/15/2023
Canada                                 6.0                       6.0              4/15/2023
India                                  5.0                       3.3              4/15/2023
Korea                                  4.0                       4.0              4/15/2023
Hong Kong                              3.0                       3.0              4/15/2023
Other countries                        9.6                       9.0             Open ended
Total             $                   45.1      $               41.7



                                       53

--------------------------------------------------------------------------------

  Table of Contents
Analysis of Cash Flows
The following table summarizes our cash flows for the first quarter and
prior-year quarter:
                                                                       Three Months Ended March 31,
(In millions)                                                            2021                  2020

Net cash provided by operating activities from continuing operations

                                                         $          0.7          $     14.3
Net cash used in investing activities from continuing operations             (8.1)               (8.8)

Net cash provided by (used in) financing activities from continuing operations

                                                         0.6                (0.1)


Net cash provided by operating activities from continuing operations during the
first quarter was $0.7 million compared to $14.3 million for the prior-year
quarter. The period-over-period change was primarily due to the change in
accounts receivable and inventory, partially offset by the change in accounts
payable and lower tax payments.
Net cash used by investing activities from continuing operations during the
first quarter was $8.1 million compared to $8.8 million during the prior-year
quarter. The period-over-period change was primarily due to lower capital
expenditures in the current period.
Net cash provided by financing activities from continuing operations during the
first quarter was $0.6 million compared to $0.1 million of cash used during the
prior-year quarter. The period-over-period change was primarily due to higher
proceeds received from the exercise of stock options in the current period.
Defined Benefit Pension Plans
Based on the U.S. advance-funded plans' status during the first quarter and the
prior-year quarter, there were no minimum required payments under ERISA. We made
contributions of $0.2 million and $0.1 million, respectively, to the U.S.
pension plans during the first quarter and prior-year quarter. We intend to fund
non-U.S. pension plans based upon applicable legal requirements, as well as
actuarial and trustee recommendations. We contributed $0.2 million
and $0.5 million, respectively, to the non-U.S. plans during the first quarter
and the prior-year quarter. Please refer to Note 8, "Pension Plans and Other
Postretirement Benefit Plans," in the Notes to the unaudited Consolidated
Financial Statements included in Item 1, "Financial Statements" of this
Quarterly Report on Form 10-Q for further discussion on our pension and other
postretirement benefit plans.
Debt and Other Contractual Obligations
Debt
Total debt outstanding at March 31, 2021 and December 31, 2020 was $351.4
million and $351.7 million, respectively. Our debt service requirements are
expected to be funded through our existing sources of liquidity and operating
cash flows. Subject to certain conditions stated in the Indenture, we may, at
our option and at any time and from time to time, redeem the 5.5% Senior Notes
prior to their maturity date in whole or in part at certain redemption prices,
as discussed in Note 8, "Debt and Other Borrowings", in the Notes to the
Consolidated Financial Statements included in Item 8, "Financial Statements and
Supplementary Data" of the 2020 Annual Report on Form 10-K.
For further information on our 5.5% Senior Notes and Credit Agreement, please
refer to Note 5, "Debt and Other Borrowings" in the Notes to the unaudited
Consolidated Financial Statements included in Item 1, "Financial Statements" on
this Quarterly Report on Form 10-Q.
Other Contractual Obligations and Contingencies
We have various future contractual obligations, including those for debt and
related interest payments, pension funding requirements, operating leases and
other operating commitments. During the first quarter, there were no material
changes to our contractual obligations as previously reported in the
"Management's Discussion and Analysis of Financial Condition and Results of
Operations - Financial Condition, Liquidity and Capital Resources" in the Annual
Report on Form 10-K for the year ended December 31, 2020.
Please refer to Note 11, "Commitments and Contingencies", in the Notes to the
unaudited Consolidated Financial Statements included in Item 1, "Financial
Statements" of this Quarterly Report on Form 10-Q for a discussion of financial
assurances and other contingencies.
                                       54
--------------------------------------------------------------------------------

  Table of Contents
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
For information on our significant accounting policies and estimates, please
refer to Note 1, "Basis of Presentation and Summary of Significant Accounting
and Financial Reporting Policies" in the Notes to the unaudited Consolidated
Financial Statements included in Item 1, "Consolidated Financial Statements" of
this Quarterly Report on Form 10-Q and in the Notes to our audited Consolidated
Financial Statements included in Item 8, "Financial Statements and Supplementary
Data" of our 2020 Annual Report on Form 10-K for the year ended December 31,
2020.
We grant equity awards to certain key employees which include restricted share
units ("RSUs"), as well as stock options and performance-based units ("PBUs")
with and without market conditions in accordance with provisions of the GCP
Applied Technologies Inc. Equity and Incentive Plan (the "Plan"), as amended and
restated on February 28, 2017, and the GCP Applied Technologies Inc. 2020
Inducement Plan (the "Inducement Plan") adopted on October 1, 2020. We make
estimates related to the likelihood of achieving performance goals for PBUs that
vest upon the satisfaction of these goals. The number of shares ultimately
provided to employees who received a PBU grant will be based on the level of
achievement of these Company targets. PBUs are remeasured during each reporting
period based on the expected payout of the award, which may range from 0% to
200% of the targets for such awards, as described in Note 14, "Stock Incentive
Plans", in the Notes to the unaudited Consolidated Financial Statements included
in Item 1, "Consolidated Financial Statements" of this Quarterly Report on Form
10-Q. As a result, these awards are subject to volatility until the payout is
determined at the end of the performance period. A hypothetical change in the
expected payout target of PBUs granted in 2021 and 2020 from 100% to 0% would
result in a stock-based compensation expense reductions of $1.2 million during
the first quarter.
                                       55
--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses